These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3082104)

  • 1. Anti-D in a 'D positive' mother giving rise to severe haemolytic disease of the newborn. A dilemma in antenatal immunohaematological testing.
    Ostgård P; Fevang F; Kornstad L
    Acta Paediatr Scand; 1986 Jan; 75(1):175-8. PubMed ID: 3082104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First report from India of haemolytic disease of newborn by anti-c and anti-E in Rh (D) positive mothers.
    Thakral B; Agrawal SK; Dhawan HK; Saluja K; Dutta S; Marwaha N
    Hematology; 2007 Oct; 12(5):377-80. PubMed ID: 17852437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemolytic disease of the fetus and newborn.
    de Haas M; Thurik FF; Koelewijn JM; van der Schoot CE
    Vox Sang; 2015 Aug; 109(2):99-113. PubMed ID: 25899660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocked D phenomenon, a rare condition with Rh D haemolytic disease of newborn - a case report.
    Sulochana PV; Rajesh A; Mathai J; Sathyabhama S
    Int J Lab Hematol; 2008 Jun; 30(3):244-7. PubMed ID: 18205842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against Rh D-haemolytic disease of the newborn by a diminished transport of maternal IgG to the fetus.
    Dooren MC; Engelfriet CP
    Vox Sang; 1993; 65(1):59-61. PubMed ID: 8362516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Rh antigen Tar (Rh40) causing haemolytic disease of the newborn.
    Levene C; Sela R; Grunberg L; Gale R; Lomas C; Tippett P
    Clin Lab Haematol; 1983; 5(3):303-5. PubMed ID: 6418437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-D concentration in mother and child in haemolytic disease of the newborn.
    Hughes-Jones NC; Ivona M; Ellis J; Walker W
    Vox Sang; 1971 Aug; 21(2):135-40. PubMed ID: 5000958
    [No Abstract]   [Full Text] [Related]  

  • 8. Serological and immunological characteristics of maternal anti-Rh(D) antibodies in predicting the severity of haemolytic disease of the newborn.
    Zupańska B; Brojer E; Richards Y; Lenkiewicz B; Seyfried H; Howell P
    Vox Sang; 1989; 56(4):247-53. PubMed ID: 2503936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three examples of Rh haemolytic disease of the newborn with a negative direct antiglobulin test.
    Heddle NM; Wentworth P; Anderson DR; Emmerson D; Kelton JG; Blajchman MA
    Transfus Med; 1995 Jun; 5(2):113-6. PubMed ID: 7655573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
    Vućinović M; Jadrić H; Karelović D; Roje D; Haspl-Hundrić Z; Hrgović Z; Vućinović Z
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal hemolytic disease of a newborn due to anti-D in an Rh-positive Du variant mother.
    Lacey PA; Caskey CR; Werner DJ; Moulds JJ
    Transfusion; 1983; 23(2):91-4. PubMed ID: 6404025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe haemolytic disease in an infant born to an Rh(null) proposita.
    Lubenko A; Contreras M; Portugal CL; Cervi P; Forsi L; Garner SF; Pinho MO; Barbosa M; Mettrau EC; de Azevedo JG
    Vox Sang; 1992; 63(1):43-7. PubMed ID: 1413662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the protective effect of maternal FcR-blocking IgG alloantibodies HLA-DR in Rh D-haemolytic disease of the newborn.
    Dooren MC; van Kamp IL; Kanhai HH; Gravenhorst JB; von dem Borne AE; Engelfriet CP
    Vox Sang; 1993; 65(1):55-8. PubMed ID: 8362515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antenatal tests in the diagnosis and assessment of severity of haemolytic disease (Hd) of the fetus and newborn (hdn).
    Contreras M
    Vox Sang; 1994; 67 Suppl 3():207-10. PubMed ID: 7975494
    [No Abstract]   [Full Text] [Related]  

  • 15. Some clinical consequences of red cell incompatibility: the Bradshaw lecture 1978.
    Mollison PL
    J R Coll Physicians Lond; 1979 Jan; 13(1):15-20. PubMed ID: 105132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rh(D) fraction incompatibility causing hemolytic disease of the newborn. Report of two cases in a Chinese family.
    Lee SK; Tham KT; Cheung KP; Jenkins WJ
    Am J Clin Pathol; 1982 Jul; 78(1):95-6. PubMed ID: 6808826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemolytic disease of the newborn due to Rhesus anti-e antibody.
    Chapman J; Waters AH
    Vox Sang; 1981; 41(1):45-7. PubMed ID: 6798758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case for the antenatal administration of anti-D immunoglobulin to primigravidae.
    Tovey LA; Taverner JM
    Lancet; 1981 Apr; 1(8225):878-81. PubMed ID: 6112301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Ce complicating two consecutive pregnancies with increasing severity of haemolytic disease of the newborn.
    Ranasinghe E; Goodyear E; Burgess G
    Transfus Med; 2003 Feb; 13(1):53-5. PubMed ID: 12581455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal hemolytic disease due to anti-Rh17 alloimmunization.
    Hirose M; Nakanishi K; Kaku S; Moro H; Hodohara K; Aotani H; Takebayashi K; Noda Y
    Fetal Diagn Ther; 2004; 19(2):182-6. PubMed ID: 14764967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.